Clinical Trial: A Study to Investigate the Pharmacokinetics and Safety of KM04 Compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in Healthy Adult Female Volunteers

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07794683) titled 'A Study to Investigate the Pharmacokinetics and Safety of KM04 Compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in Healthy Adult Female Volunteers' on Aug. 19.

Brief Summary: A study to investigate the pharmacokinetics and safety of KM04 compared to United States (US)-Gonal-f Revised Formulation Female (RFF) Redi-ject and European Union (EU)-Gonal-f in healthy adult female volunteers

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Female Adult Volunteers

Intervention: DRUG: KM04

Participants will receive a single subcutaneous dose of 3...